Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.





Farshid Dayyani, MD

Farshid Dayyani, MD

Medical Oncology, Internal Medicine

4.9 (96)
Schedule an Appointment

Dr. Farshid Dayyani is a board-certified UCI Health medical oncologist who specializes in the treatment of gastrointestinal and hepatobiliary malignancies. His clinical interests include colorectal, esophageal, stomach, liver, bile duct, pancreatic and neuroendocrine cancers, as well as anal carcinoma.

He earned a combined medical degree and PhD in immunology at Ludwig Maximilian University of Munich in Germany. He completed a research fellowship in cancer biology and an internal medicine residency at Harvard Medical School in Boston, Mass. Next, he completed a combined clinical and research fellowship in medical oncology at the University of Texas MD Anderson Cancer Center in Houston. He later served as global clinical lead for oncology at Roche Diagnostics.

Dayyani serves as medical director of the Stern Center for Clinical Trials & Research and associate director for translational science for the Chao Family Comprehensive Cancer Center. His research focus is on innovative clinical and translational studies of gastrointestinal and hepatobiliary carcinomas with the goal of bringing leading-edge treatments to patients.

He manages a wide portfolio of investigator-initiated, National Cancer Institute-funded and industry sponsored clinical trials aimed at developing novel treatment options and establishing new biomarkers. He is also the author or co-author of more than 100 research studies published in leading medical journals.

Services:

Clinical Interests:

gastrointestinal cancers, colorectal cancer, gastric cancer, esophageal cancer, anal carcinomas, liver cancer, pancreatic cancer, neuroendocrine tumors, neuroendocrine liver metastases, bile duct cancer

Schedule an Appointment

New Patient Appointment

Select a time and fill in your information to quickly and easily schedule an appointment.

Schedule an Appointment

To schedule a new patient appointment call: 714-456-8000

Schedule an Appointment

If you're a current patient please visit the patient portal or call: 714-456-8000

Go to Patient Portal

Ratings & Reviews


Overall Rating

4.9
4.9 (96)
23 Reviews
5
4
3
2
1
0 (0)
0 (0)

Background


  • Professional Positions

    • Professor — Division of Hematology/Oncology, Department of Medicine, UC Irvine School of Medicine
    • Medical Director — Stern Center for Cancer Clinical Trials & Research, UCI Health Chao Family Comprehensive Cancer Center
    • Associate Director, Translational Science — Chao Family Comprehensive Cancer Center
    • Vice Chair — UC Irvine Institutional Review Board
    • Member — American Society of Clinical Oncology (ASCO)
    • Member — Medical Oncology Association of Southern California (MOASC)
  • Gender

    Male
  • Awards

    • Physicians of Excellence, Orange County Medical Association — 2022-2023
    • Outstanding Teacher, Hematology/Oncology Fellowship Program — UC Irvine School of Medicine, 2020
    • Achievement in Basic Science Fellowship Award — MD Anderson Cancer Center, 2011
    • Prostate Cancer Foundation Young Investigator Award — 2011
    • ASCO Cancer Foundation Merit Award — 2011, Genitourinary Cancers Symposium
    • Trainee Excellence Award — MD Anderson Cancer Center, 2010
    • Clifton D. Howe Award for Clinical Excellence — MD Anderson Cancer Center, 2009
    • American Society of Hematology Annual Meeting Travel Award, 2009

  • Board Certifications

    American Board of Internal Medicine
  • Residencies

    • Beth Israel Deaconess and Harvard Medical School
  • Languages Spoken

    Farsi, German, English

  • Fellowships

    • University of Texas M.D. Anderson Cancer Center
  • Education

    • Medical School of Munich
  • Academic Profile

    View this physician's faculty profile

Current Clinical Trials

A Long-term Follow-up Master Protocol for Participants who Received Cell or Gene Therapies in Other AstraZeneca Studies (LOCUS)
Adults
Farshid Dayyani
Liver Diseases
Pancreatic Disorders